165 related articles for article (PubMed ID: 20552466)
1. Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials.
Ferrer RA; Morrow KM; Fisher WA; Fisher JD
AIDS Care; 2010 Aug; 22(8):997-1005. PubMed ID: 20552466
[TBL] [Abstract][Full Text] [Related]
2. An information-motivation-behavioral skills model of adherence to antiretroviral therapy.
Fisher JD; Fisher WA; Amico KR; Harman JJ
Health Psychol; 2006 Jul; 25(4):462-73. PubMed ID: 16846321
[TBL] [Abstract][Full Text] [Related]
3. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence.
Amico KR; Toro-Alfonso J; Fisher JD
AIDS Care; 2005 Aug; 17(6):661-73. PubMed ID: 16036253
[TBL] [Abstract][Full Text] [Related]
4. Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model.
Starace F; Massa A; Amico KR; Fisher JD
Health Psychol; 2006 Mar; 25(2):153-62. PubMed ID: 16569106
[TBL] [Abstract][Full Text] [Related]
5. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
McGowan I; Taylor DJ
Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
[TBL] [Abstract][Full Text] [Related]
6. The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico.
Santillán Torres Torija C; Villagrán Vázquez G; Robles Montijo SS; de Lourdes Eguiluz Romo L
J Int Assoc Provid AIDS Care; 2015; 14(4):335-42. PubMed ID: 25979257
[TBL] [Abstract][Full Text] [Related]
7. The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample.
Amico KR; Barta W; Konkle-Parker DJ; Fisher JD; Cornman DH; Shuper PA; Fisher WA
AIDS Behav; 2009 Feb; 13(1):66-75. PubMed ID: 17876697
[TBL] [Abstract][Full Text] [Related]
8. Microbicides for HIV prevention: reality or hope?
McGowan I
Curr Opin Infect Dis; 2010 Feb; 23(1):26-31. PubMed ID: 19935418
[TBL] [Abstract][Full Text] [Related]
9. Microbicide research: current and future directions.
Ramjee G
Curr Opin HIV AIDS; 2010 Jul; 5(4):316-21. PubMed ID: 20543607
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
11. New microbicides enter trials in United States.
AIDS Alert; 2005 Jan; 20(1):10-1. PubMed ID: 15717357
[TBL] [Abstract][Full Text] [Related]
12. Microbicide clinical trial adherence: insights for introduction.
Woodsong C; MacQueen K; Amico KR; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack S
J Int AIDS Soc; 2013 Apr; 16(1):18505. PubMed ID: 23561044
[TBL] [Abstract][Full Text] [Related]
13. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
14. An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings.
Horvath KJ; Smolenski D; Amico KR
AIDS Care; 2014 Feb; 26(2):142-51. PubMed ID: 23724908
[TBL] [Abstract][Full Text] [Related]
15. Content analysis of local newspaper coverage of the microbicide trials in South Africa.
Cooper S; Anafi P; Sun C; Naidoo N; Reddy P; Buchanan D
Int Q Community Health Educ; 2008-2009; 29(2):105-21. PubMed ID: 19546087
[TBL] [Abstract][Full Text] [Related]
16. Will microbicide trials yield unbiased estimates of microbicide efficacy?
Trussell J; Dominik R
Contraception; 2005 Dec; 72(6):408-13. PubMed ID: 16307961
[TBL] [Abstract][Full Text] [Related]
17. Motivation to reduce HIV risk behaviors in the context of the Information, Motivation and Behavioral Skills (IMB) model of HIV prevention.
Kalichman SC; Picciano JF; Roffman RA
J Health Psychol; 2008 Jul; 13(5):680-9. PubMed ID: 18519441
[TBL] [Abstract][Full Text] [Related]
18. The relationship-oriented information-motivation-behavioral skills model: a multilevel structural equation model among dyads.
Harman JJ; Amico KR
AIDS Behav; 2009 Apr; 13(2):173-84. PubMed ID: 18259851
[TBL] [Abstract][Full Text] [Related]
19. Topical microbicides to prevent HIV: clinical drug development challenges.
Hendrix CW; Cao YJ; Fuchs EJ
Annu Rev Pharmacol Toxicol; 2009; 49():349-75. PubMed ID: 19006450
[TBL] [Abstract][Full Text] [Related]
20. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
Joglekar NS; Joshi SN; Deshpande SS; Parkhe AN; Katti UR; Mehendale SM
Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
